<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">The cytopathic effect (CPE)-based cell viability assay, quantification of viral RNA by real time RT-PCR assay, and the plaque-based yield reduction assay are classical analytic tools for quantitative determination of YFV replication and yields (
 <xref rid="bib7" ref-type="bibr">de Freitas et al., 2019</xref>; 
 <xref rid="bib11" ref-type="bibr">Guo et al., 2016</xref>; 
 <xref rid="bib23" ref-type="bibr">Liu et al., 2017</xref>). A YFV replicon that expresses Renilla luciferase in a replication-dependent manner was also employed for antiviral compound screening (
 <xref rid="bib28" ref-type="bibr">Patkar et al., 2009</xref>). Recently, we developed an interferon Î² promotor-driven-luciferase reporter assay for indirect quantification of viral RNA replication and discovery of antiviral drugs, including YFV (
 <xref rid="bib12" ref-type="bibr">Guo et al., 2014</xref>; 
 <xref rid="bib24" ref-type="bibr">Ma et al., 2018</xref>).
</p>
